Thibaut du Fayet
Chief Executive Officer presso PHAXIAM THERAPEUTICS S.A.
Profilo
Thibaut du Fayet is currently the Chief Executive Officer at PHAXIAM Therapeutics SA since 2023.
Previously, he worked as the Deputy Chief Executive Officer at Pherecydes Pharma SA in 2022, Director-Marketing & Strategy at bioMérieux SA, Director at Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd., and Vice President-Business Development & Marketing at Transgene SA from 2008 to 2013.
He also worked as the Head-Marketing at Stallergenes SA from 2007 to 2008.
Mr. du Fayet holds a graduate degree from Brandeis University and an MBA from ESSEC Business School, which he received in 1992.
Posizioni attive di Thibaut du Fayet
Società | Posizione | Inizio |
---|---|---|
PHAXIAM THERAPEUTICS S.A. | Chief Executive Officer | 23/06/2023 |
Precedenti posizioni note di Thibaut du Fayet
Società | Posizione | Fine |
---|---|---|
STALLERGENES | Sales & Marketing | 01/01/2008 |
BIOMÉRIEUX | Sales & Marketing | - |
PHERECYDES PHARMA | Chief Executive Officer | - |
Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd.
Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. engages in theresearch and development, and manufacture of immunotherapies for the treatment of oncology and infectious diseases. Its business scope includes biopharmaceutical technology development, technology transfer, and related technical advisory services. The company was founded on July 26, 2010 and is headquartered in Tianjin, China. | Director/Board Member | - |
TRANSGENE | Corporate Officer/Principal | - |
Formazione di Thibaut du Fayet
Brandeis University | Graduate Degree |
ESSEC Business School | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
TRANSGENE | Health Technology |
BIOMÉRIEUX | Health Technology |
PHAXIAM THERAPEUTICS S.A. | Health Technology |
Aziende private | 3 |
---|---|
Stallergenes SA
Stallergenes SA Pharmaceuticals: MajorHealth Technology Stallergenes SA is an international biopharmaceutical company, which engages in the manufacture and sale of pharmaceutical products for the treatment of allergy-related respiratory diseases. The company operates through the Allergen Immunotherapy segment, which provides products and services for the desensitization of allergy-related respiratory conditions. Its products include a range of sublingual route and subcutaneous route products for the treatment of respiratory diseases such as rhino-conjunctivitis, rhinitis, and allergic asthma. Stallergenes was founded in 1962 and is headquartered in Antony, France. | Health Technology |
Pherecydes Pharma SA
Pherecydes Pharma SA Pharmaceuticals: MajorHealth Technology Pherecydes Pharma SA is a biotechnology company, which engages in the research and development of anti-infective therapies based on the use of bacteriophages. It develops phage treatments of bacterial infections. The company was founded by Jerome Gabard and Manuel Gea in December 2006 and is headquartered in Romainville, France. | Health Technology |
Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd.
Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. engages in theresearch and development, and manufacture of immunotherapies for the treatment of oncology and infectious diseases. Its business scope includes biopharmaceutical technology development, technology transfer, and related technical advisory services. The company was founded on July 26, 2010 and is headquartered in Tianjin, China. | Commercial Services |
- Borsa valori
- Insiders
- Thibaut du Fayet